Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medivation Inc (NASDAQ:MDVN)

57.52
Delayed Data
As of May 03
 -0.49 / -0.84%
Today’s Change
26.41
Today|||52-Week Range
66.40
+18.99%
Year-to-Date

Today’s Trading

Previous close58.01
Today’s open58.00
Day’s range57.50 - 58.85
Volume3,741,431
Average volume (3 months)3,232,436
Market cap$9.5B
Dividend yield--
Data as of 05/03/2016

Growth & Valuation

Earnings growth (last year)-15.48%
Earnings growth (this year)-23.50%
Earnings growth (next 5 years)+29.59%
Revenue growth (last year)+32.76%
P/E ratio39.2
Price/Sales8.68
Price/Book10.90

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-0.10-0.07%
VRXValeant Pharmaceutic...+3.14+9.62%
RDYDr.Reddy's Laborator...-0.18-0.40%
IDXXIDEXX Laboratories I...-0.13-0.15%
Data as of 05/03/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)$0.18
Annual revenue (last year)$943.3M
Annual profit (last year)$244.7M
Net profit margin25.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David T. Hung
Chief Operating Officer
Marion McCourt
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs